N@N

Market Maker Surveillance Report. WIN, MS, STD, SLXP, ASML, AMGN, Highest Net Sell Volume and Negative Price Friction For Thur

December 1, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Thursday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Thursday there were 3664 companies with "abnormal" market making, 2468 companies with positive Friction Factors and 3406 companies with negative Friction Factors. Here is a list of the top companies with the highest net sell volume on Thursday and lowest negative price Friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. WINDSTREAM CORP (NYSE:WIN), MORGAN STANLEY (NYSE:MS), BANCO SANTANDER SA-SPON ADR (NYSE:STD), SALIX PHARMACEUTICALS LTD (NASDAQ:SLXP), ASML HOLDING NV-NY REG SHS (NASDAQ:ASML), AMGEN INC (NASDAQ:AMGN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     WIN        $-0.070      -0.60%       4,045,142       34.82%       7,566,950       65.14%       -3,521,808      -503,115
     MS         $-0.210      -1.44%       7,856,131       31.17%       9,074,892       36.01%       -1,218,761      -58,036 
     STD        $-0.010      -0.13%       777,735         7.94%        2,987,575       30.51%       -2,209,840      -2,209,840
     SLXP       $-0.630      -1.43%       520,456         43.14%       2,784,243       230.77%      -2,263,787      -35,933 
     ASML       $-0.210      -0.53%       1,174,843       31.65%       2,446,646       65.92%       -1,271,803      -60,562 
     AMGN       $-0.350      -0.60%       4,425,078       41.93%       5,536,619       52.47%       -1,111,541      -31,758 

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have low price friction combined with more selling than buying (negative Net Volume) in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows WIN down $-0.07000 with a Friction Factor of -503,115 and a Net Volume of -3,521,808. That means that it takes 503,115 more shares of selling than buying to drop WIN by one penny. On Monday the Market Makers allowed the stock to move down on heavier selling than buying (low negative friction).

WINDSTREAM CORP (NYSE:WIN) - Windstream Corporation, together with its subsidiaries, provides various telecommunications services primarily in rural areas in the United States. It offers phone, high-speed Internet, and digital television services. The company also offers a range of Internet protocol based voice and data services, and advanced phone systems and equipment to businesses and government agencies. In addition, it provides various enhanced service features, including call waiting, call forwarding, caller identification, three-way calling, no-answer transfer, and voicemail. Further, the company offers other telecommunications services, including interconnection, long distance, and custom calling services. It serves residential and business customers. As of December 31, 2009, Windstream Corporation operated 55 retail stores and 2 call centers. The company is based in Little Rock, Arkansas.

MORGAN STANLEY (NYSE:MS) - Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. It operates in three segments: Institutional Securities, Global Wealth Management Group, and Asset Management. The Institutional Securities segment offers financial advisory services on mergers and acquisitions, divestitures, joint ventures, corporate restructurings, recapitalizations, spin-offs, exchange offers, and leveraged buyouts and takeover defenses, as well as shareholder relations, capital raising, corporate lending, and investments. This segment also engages in sales, trading, financing, and market-making activities, including equity trading, commodities, and interest rates, credit, and currencies, as well as financing services, such as prime brokerage, consolidated clearance, settlement, custody, financing, and portfolio reporting services. The Global Wealth Management Group segment provides brokerage and investment advisory services covering various investment alternatives comprising equities, options, futures, foreign currencies, precious metals, fixed income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs; education savings programs, financial and wealth planning services, and annuity and insurance products; credit and other lending products; cash management services; retirement services; and trust and fiduciary services. The Asset Management segment offers products and services in equity, fixed income, and alternative investments, such as hedge funds, fund of funds, real estate, private equity, and infrastructure to institutional and retail clients through proprietary and third party distribution channels. This segment also involves in investment and merchant banking activities. The company was founded in 1935 and is headquartered in New York.

BANCO SANTANDER SA-SPON ADR (NYSE:STD) - Banco Santander, S.A. provides various financial products and services in Spain, the United Kingdom, Portugal, other European countries, Brazil, Latin America, and the United States. It operates through three segments: Retail Banking, Global Wholesale Banking, and Asset Management and Insurance. The Retail Banking segment offers a range of deposit products, including savings, current, demand, time, and notice deposits, as well as international and domestic interbank deposits; and loan products and services, such as auto financing, personal loans, mortgages, and leasing and renting. This segment also offers credit cards, automated cash dispensers, savings books updaters, telephone banking, and electronic and Internet banking. The Global Wholesale Banking segment provides corporate banking, treasury, and investment banking services. Its products and services include cash management, trade finance, and basic financing; corporate finance for mergers and acquisitions, and asset and capital structuring; and origination activities, risk management, and distribution of structured products and debt. This segment also engages in the trading and distribution of equities. The Asset Management and Insurance segment involves in the design and management of mutual and pension funds, and insurance products. As of September 30, 2010, Banco Santander had 6,075 branch offices in Continental Europe; 1,328 branches in the United Kingdom; 5,784 branches in Latin America; and 723 branches in the Sovereign. The company was formerly known as Banco Santander Central Hispano SA and changed its name to Banco Santander, S.A. in 2007. Banco Santander, S.A. was founded in 1857 and is headquartered in Madrid, Spain.

SALIX PHARMACEUTICALS LTD (NASDAQ:SLXP) - Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States. The companys marketing products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; OsmoPrep and Visicol tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Apriso, for the maintenance of remission of ulcerative colitis in adults. Its marketing products also comprise Metozolv ODT orally disintegrating tablets for the relief of symptomatic gastroesophageal reflux or short-term therapy for adults; Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis; Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer, and gastro-esophageal reflux diseases; and Colazal capsules for the treatment of ulcerative colitis. In addition, the company has products under development for the treatment of irritable bowel syndrome, HIV-associated diarrhea, gastroenterology, ulcerative colitis, and ulcerative proctitis or proctosigmoiditis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; CedarsSinai Medical Center; Clinical Development Capital Partnership; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Lupin, Ltd.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; Photocure ASA; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina.

ASML HOLDING NV-NY REG SHS (NASDAQ:ASML) - ASML Holding N.V., through its subsidiaries, engages in designing, manufacturing, marketing, and servicing semiconductor processing equipment used in the fabrication of integrated circuits. The company offers a portfolio of lithography systems for manufacturing semiconductors, integrated circuits, or chips. Its PAS 5500 product family comprises wafer steppers, and step and scan systems suitable for the i-line, krypton fluoride, and argon fluoride processing of wafers. The company also provides TWINSCAN, a dual-stage design system that allows wafer measurement. In addition, it offers Tachyon SMO, a source-mask optimization product that allows co-optimization of source and mask; and programmable illumination and BaseLiner scanner matching technology, which offers scanner stability optimization and stabilizes manufacturing process windows. The company operates principally in Japan, Korea, Singapore, Taiwan, Europe, and the United States. It has strategic alliance with Zeiss. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.

AMGEN INC (NASDAQ:AMGN) - Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the bodys response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net